PHSL-63-SYM AND PHS-63-SYM PEDIATRIC HEAD AND SPINE ARRAY COILS
K024354 · Mri Devices Corp. · MOS · Jan 9, 2003 · Radiology
Device Facts
| Record ID | K024354 |
| Device Name | PHSL-63-SYM AND PHS-63-SYM PEDIATRIC HEAD AND SPINE ARRAY COILS |
| Applicant | Mri Devices Corp. |
| Product Code | MOS · Radiology |
| Decision Date | Jan 9, 2003 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 892.1000 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Intended Use
To be used in conjunction with a Magnetic Resonance Scanner to produce diagnostic images of the pediatric head and spine, that can be interpreted by a trained physician.
Device Story
Pediatric Head and Spine Array Coils (Model PHSL-63-SYM and PHS-63-SYM) function as radiofrequency (RF) receiver coils for Magnetic Resonance Imaging (MRI) systems. Devices capture RF signals emitted by patient tissue within an MRI scanner bore; signals are processed by the host MRI system to generate diagnostic images of pediatric head and spine anatomy. Used in clinical radiology settings by trained technologists and interpreted by physicians to assist in clinical diagnosis. Devices are passive hardware components designed for pediatric-specific geometry.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
RF receiver coil array for MRI. Pediatric-specific form factor. Passive hardware component. Compatible with standard clinical MRI scanners. No software or active electronic components.
Indications for Use
Indicated for use in pediatric patients requiring diagnostic imaging of the head and spine via Magnetic Resonance Scanner. Prescription use only.
Regulatory Classification
Identification
A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).
Special Controls
*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
Related Devices
- K013514 — PHSL-63 PEDIATRIC HEAD AND SPINE ARRAY COIL · Mri Devices Corp. · Jan 2, 2002
- K081322 — MAGNETIC RESONANCE DIAGNOSTIC DEVICE, MODEL 0100140201, PEDIATRIC HEAD-SPINE COIL · Shanghai Chenguang Medical Technologies Co, Ltd. · Jun 18, 2008
- K060689 — 1.5T PEDIATRIC HEAD AND SPINE ARRAY MODEL · Resonance Innovations, LLC · Mar 31, 2006
- K101858 — PEDIATRIC HEAD-SPINE COIL (MODEL:5000012701 · Shanghai Chenguang Medical Technologies Co, Ltd. · Jul 14, 2010
- K061170 — 3.0T PEDIATRIC HEAD AND SPINE ARRAY, MODEL 808GE3000 · Resonance Innovations, LLC · May 25, 2006
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure with three distinct lines forming its body and wings. The logo is presented in black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 0 9 2003
Mr. Thomas Schubert President MRI Devices Corp. 1515 Paramount Dr. WAUKESHA WI 53186 Re: K024354
Trade/Device Name: Model PHSL-63-SYM and PHS-63-SYM Pediatric Head and Spine Array Coils Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: 90 MOS Dated: December 27, 2002 Received: December 30, 2002
Dear Mr. Schubert:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|----------------------------------|----------------|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Section C – Statement of Indications for Use:
Applicant: MRI Devices Corporation 510(k) number (if known): Model PHSL-63-SYM and PHS-63-SYM Device Name: Pediatric Head and Spine Array Coils
Indications for use:
To be used in conjunction with a Magnetic Resonance Scanner to produce diagnostic images of the pediatric head and spine, that can be interpreted by a trained physician.
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Reproduct and Radiological Devices Over-The-Counter Use_ Prescription Use or (Per 21 CFR 801.109)
(Optional Format 1-2-96)